LY4395089: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
4
Conditions studied
11
US states with sites
10
Countries
Phase breakdown
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Crohn Disease | 2 |
| Crohn's disease | 2 |
| Colitis, Ulcerative | 1 |
| Ulcerative colitis | 1 |
Recruiting trials involving LY4395089
- A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Common questions
How many recruiting trials involve LY4395089?
2 recruiting trials across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.